New U.S. Patents Granted for RegenLab

LE-MONT-SUR LAUSANNE, Switzerland, May 21, 2019 /PRNewswire/ -- Mr. Antoine Turzi, inventor, Regen Lab SA and RegenLab USA LLC are delighted to announce that the United States Patent and Trademark Office (USPTO) has issued two new U.S. patents covering its Thrombin Serum (TS), Platelet Rich Plasma (PRP) and Hyaluronic Acid (HA) technologies:

i) Systems/methods for the preparation of PRP and HA in a single "all in one" device - the CELLULAR MATRIX technology* with tubes containing HA, a thixotropic gel and an anticoagulant: U.S. Patent No. 10,272,139 and

ii) Systems for the preparation of thrombin serum and biological glue, in particular tubes containing a thixotropic gel: U.S. Patent No. 10,226,516.

These new patents represent a recognition by the USPTO of RegenLab's innovation, technology and efficiency. This is great news for RegenLab, its employees and partners, and justifies RegenLab's investment in R&D and enforcement of its intellectual property rights.

This brings a total of 10 (ten) U.S. granted patents on these technologies, expanding RegenLab's patent portfolio along with patents also recently granted in other jurisdictions:

i) Methods for the preparation of PRP by centrifuging tubes with a (polymeric) thixotropic gel (+ anticoagulant) and removing Platelet Poor Plasma (PPP), optionally combined with a cell extract or coagulation activator: US10,092,598

ii) Methods for the preparation of PRP by centrifuging tubes with only a thixotropic gel and anticoagulant, optionally combined with e.g. a coagulation activator, a cell extract, cream, filler, hydrogel, vitamin, antalgic, analgesic or HA: US10,080,770

iii) Systems for the preparation of PRP and Bone Marrow Concentrate (BMC), in particular tubes containing a thixotropic gel and anticoagulant: US10,064,894

iv) Systems/methods combining PRP and HA in two separate devices: US10,052,349

v) Systems/methods for the preparation of PRP, in particular tubes containing a thixotropic gel and sodium citrate as anticoagulant: US9,833,478

vi) Composition comprising HA, anticoagulant and thixotropic gel, tube/container containing such composition, combination with coagulation activator or cell extract: US9,517,255

vii) Methods for the preparation of HA and PRP in a single device, in particular centrifuging tubes containing HA and optionally a gel and anticoagulant, optionally combined with e.g. a coagulation activator or cell extract: US8,945,537

viii) Specific PRP compositions, tubes containing specific thixotropic gels and anticoagulants, combination with cell extracts, related methods and cell culture methods: US8,529,957.

PRP* ALONE	PRP + CELL Culture	ATS* ALONE + PRP	PRP + HA*	PRP + CELL Extract
WO2011/110948	WO2008/023026	WO2011/110948	WO2011/110948	WO2008/023026
WO2013/061309	WO2011/110948	US10226516	WO2013/061309	WO2011/110948
WO2016/083549	WO2016/083549	AU2013203115B	WO2016/083549	WO2016/083549
US10092598	US8529957	JP6359495	US10272139	US10092598
US10080770	EP2073862B	Pending EP3403659	US9517255	US10080770
US10064894	CH696752	JP2017149786	US8945537	US9517255
US9833478		CN105998067	US10052349	US8529957
US8529957		IL252122	EP3184114B	EP2073862B
EP2073862B		and CA2915649	EP2544697B1	CH696752
CH696752			CA2789533C
HK1231793			CN103079577B
Pending			JP6076091
US2018353436			AU2011225828B
EP3111974 and			IL221133
EP3395383			RU2614722
			RU2667964
			JP6076091
			JP6321119
			KR20130067247
			HK1179507
			and Pending
			US16/298,112
			7167/DELNP/2012
			JP2017149786

*PRP: Platelet Rich Plasma

*HA: Hyaluronic Acid

*ATS: Autologous Thrombin Serum
CN105998067 US2018327120 and EP2771241

About RegenLab

RegenLab is a leading innovator of medical devices for the preparation of platelet rich plasma, which it markets under the well-recognized REGENLAB, REGENKIT and CELLULAR MATRIX* brands.

RegenLab remains committed to providing pyrogen-free devices of the highest quality and safety, as well as protecting customers through enforcement of its intellectual property rights.

Additional information about RegenLab and its patents can be found at https://www.regenlab.com/corporate/ patents and https://www.regenlabusa.com.

*Only available for research purposes in the United States (not available for sale)

RegenLab USA LLC 575 Madison Avenue
Suite 1006 New York, NY 10022-2511 Phone & Fax: [phone]
www.regenlabusa.com

Regen Lab SA En Budron B2
CH - 1052 Le Mont-Sur-Lausanne
Switzerland
Tel. [phone]
Fax. [phone]
www.regenlab.com

Roberta Ruggeri, Tel. [phone]

https://mma.prnewswire.com/media/890782/Patent_document_Infographic.jpg
https://mma.prnewswire.com/media/890783/Patent_document_Infographic.jpg
https://mma.prnewswire.com/media/890784/Patent_certificate_Infographic.jpg
Logo - https://mma.prnewswire.com/media/890785/Regen_Lab_SA_Logo.jpg